Suppr超能文献

利尿剂在心力衰竭中的应用及结局。

Diuretic use in heart failure and outcomes.

机构信息

1] Monash Centre of Cardiovascular Research and Education in Therapeutics, Department of Epidemiology and Preventive Medicine, Monash University, Melbourne, Australia [2] Alfred Hospital, Melbourne, Australia [3] Department of Cardiology, Oslo University Hospital Ullevål, Oslo, Norway [4] Institute of Clinical Sciences, University of Oslo, Oslo, Norway.

出版信息

Clin Pharmacol Ther. 2013 Oct;94(4):490-8. doi: 10.1038/clpt.2013.140. Epub 2013 Jul 12.

Abstract

Diuretics are frequently administered to relieve congestive symptoms in patients with heart failure (HF). Despite their widespread use, prospective data on the potential of diuretics to modulate HF-related morbidity and mortality are scarce. Diuretic efficacy may be limited by adverse neurohormonal activation and by "congestion-like" symptoms that may occur in the absence of fluid overload. Herein, we review the current knowledge on diuretic use and outcomes in HF.

摘要

利尿剂常用于缓解心力衰竭(HF)患者的充血症状。尽管利尿剂广泛应用,但关于利尿剂调节 HF 相关发病率和死亡率的前瞻性数据却很少。利尿剂的疗效可能受到不良神经激素激活和可能在没有液体超负荷的情况下发生的“充血样”症状的限制。本文综述了 HF 中利尿剂使用和结局的现有知识。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验